KLEM-studie.

Levels Lidocaine in Newborn after an Episiotomy given to Mother.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21641

Enrollment

Registered

2012-12-19

Start date

2013-01-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perinatale transmissie van lidocaïne perinatal transmission of lidocaine

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Informed consent; 2. Delivery in Amphia Hospital; 3. Administration of lidocaine in the perineum for local anesthesia; 4. Gestation period from 32 weeks; 5. For the newborn: stay in the hospital to determine glucose levels.

Exclusion criteria

Exclusion criteria: 1. Administration of lidocaine for other purposes than local anesthesia; 2. Administration of epinefrine together with lidocaine for episiotomy.

Design outcomes

Primary

Measure	Time frame
Plasma concentration lidocaine in the newborn and in the mother on time of delivery.	—

Secondary

Measure	Time frame
Range of plasma concentration lidocaine in 24 hours in newborn.	—

Contacts

Public ContactJ. Huisbrink

Amphia Ziekenhuis, Klinische Farmacie Postbus 90158

jhuisbrink@amphia.nl

Outcome results